{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T04:29:33Z","timestamp":1773376173610,"version":"3.50.1"},"reference-count":0,"publisher":"Harborside Press, LLC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JADPRO"],"published-print":{"date-parts":[[2026,3,11]]},"abstract":"<jats:p>Introduction: In September 2021, the National Cancer Institute (NCI) expanded the ability for advanced practice providers (APP) to practice more autonomously by being able to write orders for research-related anti-cancer therapy. Objectives: The goal was to align with NCI guidance to permit APPs to independently write non-Cycle 1 Day 1 study agent orders. Methods: An academic institution created a process to comply with the NCI\u2019s memorandum. Health-system policy was updated to reflect this new capability. A tracking system was established to monitor NCI\u2019s Registration and Credentialing Roster (RCR) expiration dates. An audit process was created to verify alignment between signed electronic research-related anti-cancer therapy orders and Delegation of Tasks Logs. Results: To date, no adverse comments about APPs\u2019 abilities to sign anti-cancer trial orders have been received from organizations that accredit or support clinical trials. In addition, no APPs have lost the ability to sign anti-cancer therapy orders because they failed to renew their RCR within the expiration period. To facilitate this capability in a timely manner, a research-specific onboarding experience was created. Conclusion: APPs may safely write anti-cancer treatment orders for patients enrolled in clinical trials. Additionally, such privilege may contribute to the enhanced participation of APPs through research.<\/jats:p>","DOI":"10.6004\/jadpro.2026.17.2.4","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T20:00:32Z","timestamp":1773345632000},"page":"75-80","source":"Crossref","is-referenced-by-count":0,"title":["Blazing Trails With Research: Paving the Way for Advanced Practice Providers"],"prefix":"10.6004","volume":"17","author":[{"given":"Carlin","family":"Callaway, DNP","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie","family":"Hogan, MS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Jennrich, MBA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"Poore, MBA, CCRP","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4047","published-online":{"date-parts":[[2026,3,11]]},"container-title":["Journal of the Advanced Practitioner in Oncology"],"original-title":[],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T20:00:33Z","timestamp":1773345633000},"score":1,"resource":{"primary":{"URL":"https:\/\/jadpro.com\/issues\/volume-17-number-2-marapr-2026\/blazing-trails-with-research-paving-the-way-for-advanced-practice-providers\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":0,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,3,11]]},"published-print":{"date-parts":[[2026,3,11]]}},"URL":"https:\/\/doi.org\/10.6004\/jadpro.2026.17.2.4","relation":{},"ISSN":["2150-0878"],"issn-type":[{"value":"2150-0878","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,11]]}}}